Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand. [PDF]
Sanchat T +4 more
europepmc +1 more source
Predictive Analysis of Drug-Resistant Tuberculosis: Integrating Molecular Markers, Clinical Governance, and Community-Engaged Education in Rural South Africa. [PDF]
Conham S +5 more
europepmc +1 more source
Utility of Patch Testing, LTT, and HLA Genotyping in Identifying Culprit Drugs and Diagnosing Multiple Drug Hypersensitivity in Definite DRESS: A 10-Year Cohort Study. [PDF]
Ünal D +22 more
europepmc +1 more source
Rechallenge with First-Line Anti-Tubercular Therapy After Toxic Epidermal Necrolysis in an HIV-Positive Patient with Tubercular Pleural Effusion. [PDF]
Narula AS +3 more
europepmc +1 more source
Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment. [PDF]
Wijk M +20 more
europepmc +1 more source
Molecular docking analysis of DprE1 from <i>M. tuberculosis</i> with phytochemicals. [PDF]
Raja J, Blessy JJ.
europepmc +1 more source
Breakthrough Tuberculosis in a Large Cohort of People Living With HIV on Preventive Treatment. [PDF]
Ruswa N, Günther G, Claassens M.
europepmc +1 more source
Cost-effectiveness of latent tuberculosis infection testing and preventive treatment among TB contacts in China: a Markov model. [PDF]
Li J, Wen Y, Ge F, Qiu Y, Xu C.
europepmc +1 more source
Routine Molecular Surveillance of Drug-Resistant Tuberculosis: Translating Mutation Proxies into Clinical Governance Intelligence in Rural Eastern Cape. [PDF]
Sonka B +4 more
europepmc +1 more source

